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ABSTRACT
OBJECTIVE: To determine the prevalence of metabolic syndrome and its components in 
Brazilian adolescents. 
METHODS: We evaluated 37,504 adolescents who were participants in the Study of 
Cardiovascular Risks in Adolescents (ERICA), a cross-sectional, school-based, national study. 
The adolescents, aged from 12 to 17 years, lived in cities with populations greater than 100,000 
inhabitants. The sample was stratified and clustered into schools and classes. The criteria 
set out by the International Diabetes Federation were used to define metabolic syndrome. 
Prevalences of metabolic syndrome were estimated according to sex, age group, school type 
and nutritional status.
RESULTS: Of the 37,504 adolescents who were evaluated: 50.2% were female; 54.3% were aged from 
15 to 17 years, and 73.3% were from public schools. The prevalence of metabolic syndrome was 2.6% 
(95%CI 2.3-2.9), slightly higher in males and in those aged from 15 to 17 years in most macro-regions. 
The prevalence was the highest in residents from the South macro-region, in the younger female 
adolescents and in the older male adolescents. The prevalence was higher in public schools (2.8% 
[95%CI 2.4-3.2]), when compared with private schools (1.9% [95%CI 1.4-2.4]) and higher in obese 
adolescents when compared with nonobese ones. The most common combinations of components, 
referring to 3/4 of combinations, were: enlarged waist circumference (WC), low HDL-cholesterol 
(HDL-c) and high blood pressure; followed by enlarged WC, low HDL-c and high triglycerides; and 
enlarged WC, low HDL-c, high triglycerides and blood pressure. Low HDL was the second most 
frequent component, but the highest prevalence of metabolic syndrome (26.8%) was observed in 
the presence of high triglycerides.
CONCLUSIONS: ERICA is the first Brazilian nation-wide study to present the prevalence of 
metabolic syndrome and describe the role of its components. Despite the prevalence of Metabolic 
Syndrome being low, the high prevalences of some components and participation of others in 
the syndrome composition shows the importance of early diagnosis of this changes, even if not 
grouped within the metabolic syndrome. 
DESCRIPTORS: Adolescent. Metabolic Syndrome, epidemiology. Risk Factors. Cardiovascular 
Diseases. Cross-Sectional Studies. 
Prevalence of metabolic syndrome in adolescents Kuschnir MCC et al.
2sDOI:10.1590/S01518-8787.2016050006701
INTRODUCTION
The increasing prevalence of overweight and obese children and adolescents, which has been 
observed in several countries18, including Brazil15, represent a serious public health problem 
in terms of the various health risks that obesity can cause, both during adolescence and adult 
life. Included among the already recognized cardiovascular risk factors are those that make 
up the so-called metabolic syndrome (MS). The following are associated with MS: enlarged 
waist circumference (WC), low levels of high-density lipoprotein cholesterol (HDL-c), high 
systemic blood pressure, high triglycerides, and high blood glucose. An individual is positively 
diagnosed with MS if he/she has at least three of these conditions, which are related to 
cardiovascular disease and can have it as one of the adverse outcomes24.
Various proposals are set out to define MS in children and adolescents. However, no 
consensus exists on what their components or cut-off points would be, which have already 
been defined for adults. In 2004, Ferranti et al.10 proposed an adaptation of the criteria created 
by the National Cholesterol Education Program Adult Treatment Panel (NCEP-ATPIII). 
According to this MS definition, the cut-off point for WC is the 70th percentile10.
In 2007, the International Diabetes Federation (IDF) established a new concept for defining 
MS in children and adolescents. This concept considers increased WC measurement as the 
main component for defining MS. Thus, MS became being diagnosed in children aged 10 years 
or more when their WC was greater than or equal to the 90th percentile of the curve developed 
by Fernandez et al.9, and at the same time, presenting two or more of the clinical or laboratory 
criteria (low HDL-c and high blood pressure, triglycerides and high glucose). For adolescents 
aged over 16 years, the adult IDF criteria are used25. In 2014, Giannini et al.12 observed that 
using the IDF criteria resulted in lower prevalences in a sample of overweight adolescents 
when compared with the NCEP-ATPIII criteria. Tavares et al.22, during a systematic review 
of 15 articles performed with Brazilian adolescents, 11 of which are in the Southeast region, 
observed a variation of between 0% and 42.0% in MS prevalence, which depended on the 
diagnostic criteria used, being more pronounced in overweight individuals.
The objective of this study was to determine the prevalence of MS in Brazilian adolescents.
METHODS
The Estudo de Riscos Cardiovasculares em Adolescentes (ERICA – Study of Cardiovascular 
Risk in Adolescents) was designed to estimate the prevalence of cardiovascular risk factors 
that make up MS in a representative sample of adolescents aged from 12 to 17 years. The 
selected adolescents were attending the seventh, eighth and ninth year of elementary school 
or the first, second or third year of high school, in public or private schools, studied in the 
morning shift and lived in Brazilian cities with populations higher than 100,000 inhabitants. 
These school years weres chosen to include the largest possible number of adolescents aged 
from 12 to 17 years, since no information base exists regarding individual adolescent units 
for a sample selection, but only combinations of classes and years at the schools.
The sample was stratified into 32 strata, made up of the 27 Brazilian state capital cities and five 
sets of the other countryside cities, with more than 100,000 inhabitants, from each of the five 
macro-regions of Brazil. Thus, the sample is representative for medium- and large-sized cities 
at the regional and national level and for the capitals and the Federal District. Clusters were 
selected at three levels: schools, combinations of year and shift, and classes. The sampling 
weights were calculated by the product of the inverse probability of inclusion at each stage 
of the sample selection and were calibrated considering the estimates of the adolescent 
population enrolled in schools located in the geographic strata based on sex and age. The 
analysis was adjusted to account for the sample design, which was done using statistical 
routines for a complex sampling that considers the sources of variability and calibration 
with population estimates. 
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The sample size calculation considered an expected MS prevalence of 4.0% in adolescents6, 
with a maximum error level of 0.9% and a 95% confidence level, as well as a 2.97 agglomeration 
effect. A detailed description of the sampling process can be seen in Vasconcellos et al.23
To estimate the prevalence of MS, biochemical analyses were performed in the plasma. The 
fasting time required for blood collection was 12 hours, and therefore was only done with 
the morning shift students who were selected in the ERICA sample. Thus, any inference 
from the results regarding MS can only be made for students who attend the morning shift.
The sex and age variables were obtained through a self-filled questionnaire that was 
completed by the respondent on an electronic data collector (PDA) which also contained 
other questions not used in this analysis. The age variable was confirmed using school 
records. The following anthropometrical variables were measured by trained researchers: 
WC, measurement of the circumference of the right arm ( for choosing the appropriate cuff 
for measuring blood pressure), weight and height. These measurements were monitored 
throughout the collection by means of a quality control that verified their limits and 
distribution of digits.
Weight was evaluated using a P200M Líder scale, which has a capacity of up to 200 kg and 
a 50 g variation. Height was measured twice using an Altura Exata portable stadiometer 
with a 0.1 variation, with the mean of the two values obtained being the value taken into 
consideration. The weight and height measurements were used to classify the nutritional 
status, based on the body mass index calculation (BMI = weight/height2). Classifying 
the nutritional status involved using the BMI curves as proposed by the World Health 
Organization17 (2007) specified by age and sex. Adolescents considered to have an adequate 
nutritional status had a score of +1 > Z ≥ -2, overweight adolescents had a score of +2 > Z ≥ +1, 
and obese adolescents were those with a Z ≥ +2 score.
WC was measured using a Sanny inelastic measuring tape, which had 0.1 cm variation, at 
the midpoint between the bottom of the last rib and the upper curvature of the iliac crest, 
with the adolescent in a standing position, arms along the body and with his/her feet and 
abdomen relaxed.
Blood pressure was measured using a Omron 705-IT, machine, which had been validated 
for use in adolescents21. Three blood pressure measurements were taken, with the mean of 
the final two being used in the hypertension classification. Systemic blood pressure was 
considered high if the systolic blood pressure was greater than or equal to 130 mmHg, and 
the diastolic blood pressure was greater than or equal to 85 mmHg.
Blood sample analyses of biochemical parameters that are included in MS (HDL-c, 
triglycerides and glucose) were performed in only one laboratory that followed the current 
required quality standards for its qualification. Fasting blood glucose was analyzed with 
the GOD-PAP enzymatic method in the Roche modular analytical equipment. Values of 
100 mg/dL or more were considered as discriminants of high blood glucose2. Triglycerides 
and HDL-c were analyzed with the enzymatic colorimetric method using Roche modular 
analytical equipment. Reference values published in I Guidelines of Prevention of 
Atherosclerosis during Childhood and Adolescence were used20. A full description of the 
ERICA methods can be found in Bloch et al.4
A positive MS classification was given when at least three of the below components were 
present, with a mandatory requirement for enlarged WC, which is in accordance with the 
criteria from the International Diabetes Federation2:
• WC 
< 16 years: ≥ 90th percentile
≥ 16 years, male: ≥ 90 cm
≥ 16 years, male: ≥ 80 cm
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• HDL-c
< 16 years: 40 mg/dL
≥ 16 years, male: < 40 mg/dL
≥ 16 years, female: < 50 mg/dL
• Triglycerides: ≥ 150 mg/dL
• Glucose: ≥ 100 mg/dL
• Systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg
Adolescents who had any disability that would prevent weight, height and WC from being 
evaluated were excluded from this study. Pregnant women were also excluded.
Prevalences of MS were estimated with their respective 95% confidence intervals (95%CI) 
in the strata corresponding to the Brazilian macro-regions, according to sex and age 
groups, from 12 to 14 and 15 to 17 years of age. The complex sample design was taken into 
account, with weighting included due to the different probabilities of cluster selection and 
subsequent calibration by age and sex, from which the population estimates were obtaineda.
The prevalences of MS were also estimated by the schools’ status (public or private), in obese 
and nonobese adolescents, as were the risk factors that make up the IDF criterion for MS. 
Statab software 14 version was used for data analysis.
ERICA was approved by the Committee for Ethics in Research (CEP) of the Institute 
of Collective Health Studies, Universidade Federal do Rio de Janeiro (Process 45/2008) 
and by a CEP of each unit of the Federation. The adolescents who participated in this 
study agreed in writing to participate and their legal guardians signed an informed 
consent form.
RESULTS
Figure 1 presents a flow chart of the participants. We evaluated 37,504 adolescents, of 
which 60.0% were female, 54.3% were aged between 15 to 17 years and 73.3% studied in 
public schools.
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e pesquisas, 24). Available from: 
http://www.ibge.gov.br/home/
estatistica/populacao/projecao_
da_populacao/2008/projecao.pdf
b Stata Corp. Stata statistical 
software: release 14. College 
Station, Texas; 2015.
* 311 adolescents did not have results from all the tests required for diagnosing metabolic syndrome.
Figure 1. Flowchart of the participants assessed regarding the prevalence of metabolic syndrome. 
ERICA, Brazil, 2013-2014.
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The prevalence of MS in schools in Brazilian cities with more than 100,000 inhabitants, for 
students studying in the morning, is presented in Table 1. Regarding the prevalence of MS by 
sex and age group, small variations occurred in the prevalence with an overlapping of the 95% 
confidence interval (Table 2). In relation to age group, in most regions the prevalence was higher 
in adolescents aged between 15 and 17 years. However, in the South region, the prevalence of 
MS in adolescents aged between 12 and 17 years was greater than in those between 15 and 17 
years, albeit with an overlapping of the confidence intervals; for male adolescents the opposite 
occurred together with statistical significance. In the Midwest region, younger male adolescents 
showed greater MS prevalence than the older age group, from 15 to 17 years of age.
The Brazilian state capital that presented the highest MS prevalence was Belem (3.8% [95%CI 
2.7-5.2]), with the smallest being Macapa (0.9% [95%CI 0.3-2.7]), which are both in the North 
region and had the largest variations between them (Figure 2). However, when all the strata 
Table 1. Prevalences (%) and 95%CI of metabolic syndrome, sample size and estimated population 
in the set of cities with more than 100,000 inhabitants in Brazil, according to sex and age group. 
ERICA, 2013-2014.
Characteristic Age group Sample Population % 95%CI
Female 12-14 10,134 1,536,757 2.5 1.7-3.6
15-17 12,365 1,788,116 2.1 1.5-2.7
12-17 22,499 3,324,873 2.2 1.8-2.8
Male 12-14 7,016 1,552,255 2.5 2.0-3.2
15-17 7,990 1,751,833 3.3 2.5-4.2
12-17 15,006 3,304,088 2.9 2.5-3.4
Brazil 12-14 17,150 3,089,012 2.5 2.0-3.0
15-17 20.355 3,539,949 2.7 2.2-3.2
12-17 37,504 6,628,961 2.6 2.3-2.9
Table 2. Prevalences (%) and 95%CI of metabolic syndrome, sample size and estimated population 
in cities with more than 100,000 inhabitants, according to Brazilian regions, sex and age group. 
ERICA, 2013-2014.
Regions/Sex Age group Sample Population % 95%CI
North 7,233 456,416 2.3 2.0-2.8
Female 12-14 1,979 126,869 2.0 1.3-3.0
15-17 2,279 100,881 2.5 1.8-3.4
Male 12-14 1,458 127,856 1.6 0.9-2.8
15-17 1,517 100,810 3.5 2.6-4.7
Northeast 11,661 1,337,676 2.7 2.3-3.1
Female 12-14 3,314 343,871 2.2 1.3-4.0
15-17 3,722 325,047 2.3 1.7-3.3
Male 12-14 2,160 350,923 2.7 1.8-4.1
15-17 2,465 317,835 3.4 2.6-4.4
Midwest 5,441 525,340 2.2 1.7-3.0
Female 12-14 1,543 123,669 1.9 1.1-3.1
15-17 1,802 140,324 2.1 1.4-3.3
Male 12-14 1,060 124,867 3.2 1.8-5.4
15-17 1,056 136,480 1.8 1.1-3.0
Southeast 8,460 3,488,424 2.4 1.9-3.0
Female 12-14 2,141 755,994 1.9 1.0-3.7
15-17 3,024 995,770 1.9 1.1-3.1
Male 12-14 1,459 760,343 2.7 1.8-4.0
15-17 1,836 976,317 3.1 2.0-4.8
South 4,690 821,105 3.5 2.6-4.9
Female 12-14 1,157 186,354 5.7 2.5-12.7
15-17 1,538 226,094 2.1 1.0-4.3
Male 12-14 879 188,266 1.6 0.9-2.8
15-17 1,116 220,391 4.8 3.3-6.9
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from the sample are considered, the greatest MS prevalence was observed in the countryside 
cities of the South macro-region (4.1% [95%CI 2.8-5.9]).
The prevalence of MS was 2.8% in public schools (95%CI 2.4-3.2) and 1.9% in private schools 
(95%CI 1.4-2.4). In public schools, the prevalence of MS was 3.1% in male adolescents (95%CI 
2.5-3.7) and 2.6% in the females (95%CI 2.0-3.3). In private schools, the prevalence was lower 
in both male (2.5% [95%CI 1.9-3.3]) and female adolescents (1.3% [95%CI 0.9-1.9]).
The prevalences of MS in adolescents with adequate nutritional status were less than 0.2%, 
both in male (0.008% [95%CI 0.003-0.03]) and female (0.1% [95%CI 0.05-0.4]) adolescents. In 
the North, Northeast and Southeast regions the prevalence of MS in this group of adolescents 
was 0.1%, and lower still in the Midwest and South regions.
Figure  2. Prevalences (%) and 95%CI of metabolic syndrome in adolescents according to strata of the 
capital and countryside regions. ERICA, Brazil, 2013-2014.
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Table 3. Prevalences (%) and 95%CI of metabolic syndrome in overweight or obese adolescents, 
according to sex and macro-region. ERICA, Brazil, 2013-2014.
Regions/Sex
Overweight Obesity
% 95%CI % 95%CI
Brazil 3.3 2.4-4.5 21.3 18.5-24.5
Female 4.0 2.6-6.0 17.5 13.7-21.9
Male 2.6 1.6-4.1 24.5 20.1-29.6
North 3.3 2.4-4.4 24.7 20.5-29.5
Female 5.1 3.6-7.1 22.4 16.6-29.5
Male 1.3 0.7-2.6 26.3 20.1-33.6
Northeast 3.3 2.1-5.3 21.7 16.7-27.8
Female 3.5 2.2-5.6 20.1 12.2-31.2
Male 3.1 1.7-5.7 22.8 17.9-28.6
Midwest 2.1 1.2-3.0 21.7 16.1-27.9
Female 3.1 1.9-5.1 23.9 16.2-33.8
Male 1.2 0.5-2.4 20.5 14.8-27.7
Southeast 3.9 2.4-6.2 18.9 14.5-24.2
Female 4.8 2.5-9.1 11.3 7.8-16.0
Male 3.0 1.4-6.1 26.1 17.9-36.4
South 1.6 0.9-3.0 27.3 20.7-35.2
Female 1.8 0.8-4.0 31.8 19.4-47.5
Male 1.4 0.6-3.4 23.6 16.5-32.6
Table 4. Prevalences (%) and 95%CI of metabolic syndrome in adolescents by sex, age and Brazilian 
regions according to nutritional status. ERICA, 2013-2014.
Characteristic Nutritional status % 95%CI
Brazil Eutrophic 0.1 0.02-0.2
Overweight 3.3 2.4-4.5
Obese 21.3 18.5-24.5
Female Eutrophic 0.1 0.03-0.4
Overweight 4.0 2.6-6.0
Obese 17.5 13.7-21.9
Male Eutrophic 0.008 0.003-0.03
Overweight 2.6 1.6-4.1
Obese 24.5 20.1-29.6
12-14 years Eutrophic 0.01 0.006-0.04
Overweight 1.7 0.7-3.8
Obese 19.6 15.8-24.1
15-17 years Eutrophic 0.1 0.04-0.4
Overweight 4.9 3.6-6.6
Obese 23.5 19.1-28.6
North Eutrophic 0.1 0.02-0.2
Overweight 3.3 2.4-4.4
Obese 24.7 20.5-29.5
Northeast Eutrophic 0.1 0.03-0.2
Overweight 3.3 2.1-5.3
Obese 21.7 16.89-27.5
Midwest Eutrophic 0.02 0.01-0.1
Overweight 1.6 0.9-3.0
Obese 27.3 20.7-35.2
Southeast Eutrophic 0.02 0.0-0.1
Overweight 2.1 1.4-3.2
Obese 21.7 16.7-27.8
South Eutrophic 0.1 0.01-0.4
Overweight 3.9 2.5-6.2
Obese 18.9 14.5-24.2
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Table 3 shows the prevalence of MS, by region and sex, in overweight or obese adolescents. 
The prevalence of MS was more than six times greater in obese adolescents than in overweight 
adolescents. This proportion was always greater in male adolescents, with the exception 
being in the South region, in which the highest ratio among the regions was also observed. 
The prevalences of MS and the 95%CI by nutritional status, according to sex or age group 
in Brazil and the macro-regions, can be seen in Table 4.
Figure 3 shows that, in all strata from the sample, the prevalence of MS was higher in obese 
adolescents than in nonobese ones. The prevalence of MS and confidence intervals in the 
strata of the sample can be seen in Table 5.
Figure 3. Prevalences (%) and 95%CI of metabolic syndrome in obese and nonobese adolescents according to strata of the capital and 
countryside regions. ERICA, Brazil, 2013-2014.
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Regarding the composition of the MS, which according to the adopted criteria must include 
the presence of enlarged WC, 82.3% (95%CI 79.2-85.0) of the adolescents with MS were 
observed to present three components, 15.6% (95%CI 13.0-18.6) had four components, and 
2.1% (95%CI 1.0-4.5) had five components.
The most frequently observed MS component combinations were: enlarged WC, low HDL-c 
and high blood pressure at 33.4%; enlarged WC, low HDL-c and high triglycerides at 31.8%; 
and enlarged WC, low HDL-c and high triglycerides and blood pressure at 9.5%. These 
combinations of factors represented about 3/4 of all possible combinations.
Table 6 describes the prevalence of MS components throughout the sample, the prevalence 
of MS in those with each of the components and the prevalence of each component in 
adolescents with MS. About 1/3 of the adolescents had low HDL-c, which was reflected in 
the high prevalence of this component among adolescents with MS; however, less than 10.0% 
of adolescents with this variation had MS. Concerning high triglycerides, despite having 
Table 5. Prevalences (%) and 95%CI of metabolic syndrome in adolescents by capital and strata of the 
countryside regions. ERICA, Brazil, 2013-2014.
Strata
Total Nonobese Obese
% 95%CI % 95%CI % 95%CI
North Countryside 1.8 1.3-2.5 0.7 0.4-1.1 18.4 12.2-26.9
Porto Velho 3.3 1.8-5.7 0.6 0.3-1.6 32.6 19.6-49.0
Rio Branco 1.9 1.0-3.3 0.3 0.1-1.0 19.6 12.9-28.6
Manaus 2.2 1.5-3.2 0.5 0.3-1.1 21.1 13.2-31.8
Boa Vista 1.7 0.6-5.0 0.2 0-0.8 20.1 7.2-45.1
Belem 3.8 2.7-5.2 1.0 0.6-1.5 37.3 27.2-48.7
Macapa 0.9 0.3-2.7 0.1 0-0.5 22.6 6.6-54.6
Palmas 2.1 1.0-4.3 0.3 0.1-1.1 28.4 16.1-45.2
Northeast Countryside 2.9 2.2-3.8 0.9 0.5-1.8 21.3 13.0-32.9
Sao Luis 2.4 1.5-3.7 0.4 0.2-0.8 36.5 23.1-52.5
Teresina 1.6 0.8-3.2 0.2 0.1-0.8 20.6 10.6-36.3
Fortaleza 2.6 1.7-3.8 0.4 0.2-0.9 23.4 15.8-33.3
Natal 2.3 1.2-4.1 1.0 0.4-2.6 14.4 8.3-23.6
Joao Pessoa 3.0 1.8-4.9 0.5 0.1-1.8 36.2 19.5-57.1
Recife 2.7 1.9-3.9 0.8 0.3-1.8 19.3 13.7-26.6
Maceio 2.2 1.3-3.7 0.4 0.2-1.0 23.8 12.8-40.0
Aracaju 2.2 1.4-3.6 0.3 0.1-1.1 19.5 11.2-31.7
Salvador 2.6 1.5-4.3 0.8 0.4-1.4 19.9 10.1-35.5
Midwest Countryside 2.8 1.6-4.8 0.4 0.2-0.9 30.6 19.7-44.3
Campo Grande 2.2 1.2-4.2 0.4 0.1-1.3 18.3 9.4-32.6
Cuiaba 2.6 1.7-3.9 1.1 0.7-1.7 21.2 10.9-37.3
Goiania 2.1 1.2-3.8 0.3 0.1-1.0 18.4 9.7-32.2
Brasilia 1.7 1.1-2.6 0.3 0.1-0.7 17.0 11.2-24.8
Southeast Countryside 2.6 2.0-3.5 1.0 0.5-1.8 20.6 14.4-28.6
Belo Horizonte 1.3 0.8-1.9 0.6 0.3-1.1 10.8 6.2-18.2
Vitoria 2.5 1.5-4.2 0.8 0.3-2.0 21.3 10.8-37.5
Rio de Janeiro 1.9 1.3-2.7 0.5 0.2-1.1 11.6 7.5-17.7
Sao Paulo 2.1 1.5-3.0 0.5  0.3-1.1 20.2 12.9-30.4
South Countryside 4.1 2.8-5.9 0.2 0.1-0.7 30.0 22.1-39.3
Curitiba 2.0 1.3-3.2 0.9 0.3-2.2 16.3 9.7-26.0
Florianopolis 1.8 0.8-4.0 0.1 0.0-0.7 25.0 9.7-50.7
Porto Alegre 2.2 1.3-3.6 0.8 0.3-2.5 13.9 8.7-21.5
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been presented at a low prevalence compared to the other components in the total sample, 
they were present in almost half of all the adolescents with MS; and the prevalence of MS 
in those with this variation was high (26.8%), even greater than in those with the required 
component, i.e., enlarged WC (20.5%). High glucose levels, which had the lowest prevalence 
of all the components in the total sample, was associated with MS prevalence of around 
two times greater than in the presence of low HDL-c. Nearly 20.0% of adolescents with high 
blood pressure, according to the IDF criteria, were classified as having MS; and among the 
adolescents with MS, just over half had high blood pressure (Table 6). 
DISCUSSION
This was the first study performed with a representative sample of the Brazilian population, in 
this age group, in which important information is shown regarding the prevalence of MS. The 
observed prevalences varied according to the macro-region, sex and age without presenting 
any specific single pattern. The prevalence of MS in the South region was greater than in the 
other regions, mostly due to the prevalence observed in the cities with more than 100,000 
inhabitants in the countryside of this macro-region. This fact can be attributed to different 
eating habits and lifestyles in relation to the macro-regions, since these are the main factors 
in the genesis of obesity, which is a central component in MS diagnosis.
We observed higher prevalence of MS in adolescents from public schools, which indicates a 
possible association between socioeconomic factors and MS. Analyzing the characteristics 
that may vary according to socioeconomic status, such as parenting, eating habits or physical 
activities, can help in the understanding of these relationships. Some studies observed an 
opposite relationship to what was found in ERICA, i.e., a greater prevalence of MS in higher 
income individuals5,7,8. 
More than 40 MS definitions for children and adolescents exist11. The MS definition proposed 
by the IDF puts forward prevalences that tend to be lower than those estimated with other 
definitions of frequent use. Some studies with smaller proportions than those with ERICA, 
such as Alvarez et al.1, who evaluated 577 adolescents from public and private schools in 
the Brazilian city of Niteroi, RJ, Southeastern Brazil, observed an MS prevalence of 1.6% 
(95%CI 0.6-3.9) using the IDF definition and 6.0% (95%CI 3.0-7.8) using the NCEP-ATPIII 
criteria. This difference may have been due to the required presence of enlarged WC in the 
IDF definition. 
No consensus exists regarding the most suitable criteria, and adolescents represent a 
fraction of the population, whose main characteristic is defined by transformation. Therefore, 
using a more specific definition (not labeling those with a low probability of having this 
Table 6. Prevalence (%) and 95%CI of MS components in the population, of MS in adolescents with 
particular components, and of components in adolescents with MS. ERICA, Brazil, 2013-2014.
MS components Prevalence of the 
component
Prevalence of MS in 
adolescents with the 
component
Prevalence of 
the component 
in adolescents 
with MS
% 95%CI % 95%CI %
WCa 12.6 11.6-13.7 20.5 18.2-22.9 100
HDL-cb 32.7 30.3-35.2 7.2 6.3-8.2 90.7
Triglyceridesa 4.6 4.1-5.1 26.8 22.4-31.7 47.6
Glucosea 4.1 3.5-4.8 15.0 10.8-20.4 20.6
Blood pressurea 8.2 7.6-8.9 18.7 15.6-22.1 57.6
MS: metabolic syndrome; WC: waist circumference; HDL-c: HDL-cholesterol
a High.
b Low.
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syndrome or their false-positives as MS patients) seems more appropriate than using a 
more sensitive criterion.
During ERICA, the prevalence of MS among the obese only differed in terms of sex in the North 
and Southeast regions. In the North, it was higher among female overweight adolescents; 
and in the Southeast, it was obese males. Most research projects report a higher prevalence 
in male adolescents21,23.
While using data on adolescents from the National Health and Nutrition Examination Survey 
(NHANES), Laurson et al.13 noted, in accordance with the NCEP-ATPIII criteria, an 0.8% 
prevalence of MS in 1,785 male adolescents with adequate nutritional status (95%CI 0.1-1.5), 
6.8% in overweight individuals (95%CI 1.2-12.4) and 35.4% in the obese (95%CI 27.1-43.7). 
In 1,600 female adolescents, we observed MS prevalence of 1.7% for individuals who were 
neither overweight or obese (95%CI 0.1-3.3), 9.2% for overweight females (95%CI 4.4-14.0) 
and 24.6% for the obese (95%CI 17.2-31.9). In this study, the prevalence of MS was lesser 
in both male and female adolescents, regardless of nutritional status, when compared to 
the prevalence found in the study by Laurson et al., albeit with different criteria employed. 
Nasreddine et al.16, while using the IDF criteria, observed a prevalence of 21.2% in obese 
Lebanese adolescents, 3.8% in the overweight and 1.2% in individuals who were neither 
overweight or obese, which are similar results to those observed during ERICA.
In this study, the prevalence of the MS components, observed in adolescents with MS, in 
descending order, were: enlarged WC, low HDL-c, high triglycerides, blood pressure and 
glucose levels. Nasreddine et al.16 observed a similar descending order. However, analyzing 
the contribution of each MS component enables the visualization of the importance of 
the individualized model. Despite the prevalence of low HDL-c having been singularly the 
highest, the prevalence of MS was higher in adolescents with high triglycerides or high 
blood pressure. In other words, according to the IDF criteria, the triglycerides represented 
a relevant component. 
MS is directly associated with insulin resistance and it is this that enables the promotion and 
explanation of the emergence, prevalence and magnitude of each of the MS components3,14,19. 
The presence of only one of the MS components supports non-medicinal interventions, such 
as promoting healthy lifestyle habits, in addition to follow-up at health services. Despite 
the MS prevalences having been low during ERICA, we observed a strong association 
with nutritional status, which indicates that preventing obesity can have a significant 
impact on reducing MS prevalence as well as its subsequent cardiovascular complications 
during adult life.
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